Your browser doesn't support javascript.
loading
High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma.
Morales-Vásquez, Flavia; Pedernera, Enrique; Reynaga-Obregón, Jesús; López-Basave, Horacio Noé; Gómora, María José; Carlón, Elisa; Cárdenas, Sandra; Silva-Ayala, Raúl; Almaraz, Miguel; Méndez, Carmen.
Afiliação
  • Morales-Vásquez F; Medical Oncology Department, National Cancerology Institute, Mexico City, Mexico.
  • Pedernera E; Embryology Department, School of Medicine, National Autonomous University of Mexico (Universidad Nacional Autonoma de Mexico-UNAM-), Mexico City, Mexico.
  • Reynaga-Obregón J; Public Health Department, School of Medicine, National Autonomous University of Mexico (Universidad Nacional Autonoma de Mexico-UNAM-), Mexico City, Mexico.
  • López-Basave HN; Medical Oncology Department, National Cancerology Institute, Mexico City, Mexico.
  • Gómora MJ; Embryology Department, School of Medicine, National Autonomous University of Mexico (Universidad Nacional Autonoma de Mexico-UNAM-), Mexico City, Mexico.
  • Carlón E; Embryology Department, School of Medicine, National Autonomous University of Mexico (Universidad Nacional Autonoma de Mexico-UNAM-), Mexico City, Mexico.
  • Cárdenas S; Embryology Department, School of Medicine, National Autonomous University of Mexico (Universidad Nacional Autonoma de Mexico-UNAM-), Mexico City, Mexico.
  • Silva-Ayala R; Embryology Department, School of Medicine, National Autonomous University of Mexico (Universidad Nacional Autonoma de Mexico-UNAM-), Mexico City, Mexico.
  • Almaraz M; Embryology Department, School of Medicine, National Autonomous University of Mexico (Universidad Nacional Autonoma de Mexico-UNAM-), Mexico City, Mexico.
  • Méndez C; Embryology Department, School of Medicine, National Autonomous University of Mexico (Universidad Nacional Autonoma de Mexico-UNAM-), Mexico City, Mexico. mendezmc@unam.mx.
J Ovarian Res ; 9(1): 41, 2016 Jul 07.
Article em En | MEDLINE | ID: mdl-27388275

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Biomarcadores Tumorais / Cistadenocarcinoma Seroso / Antígeno Ca-125 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: J Ovarian Res Ano de publicação: 2016 Tipo de documento: Article País de afiliação: México País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Biomarcadores Tumorais / Cistadenocarcinoma Seroso / Antígeno Ca-125 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: J Ovarian Res Ano de publicação: 2016 Tipo de documento: Article País de afiliação: México País de publicação: Reino Unido